rs77716946
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000093.5(COL5A1):c.1936-21G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0342 in 1,612,444 control chromosomes in the GnomAD database, including 1,094 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.027 ( 84 hom., cov: 33)
Exomes 𝑓: 0.035 ( 1010 hom. )
Consequence
COL5A1
NM_000093.5 intron
NM_000093.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.47
Publications
4 publications found
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 9-134761904-G-A is Benign according to our data. Variant chr9-134761904-G-A is described in ClinVar as Benign. ClinVar VariationId is 255058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0273 (4161/152326) while in subpopulation NFE AF = 0.0393 (2675/68030). AF 95% confidence interval is 0.0381. There are 84 homozygotes in GnomAd4. There are 2045 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 4161 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.1936-21G>A | intron_variant | Intron 18 of 65 | ENST00000371817.8 | NP_000084.3 | ||
| COL5A1 | NM_001278074.1 | c.1936-21G>A | intron_variant | Intron 18 of 65 | NP_001265003.1 | |||
| COL5A1 | XM_017014266.3 | c.1936-21G>A | intron_variant | Intron 18 of 64 | XP_016869755.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0274 AC: 4163AN: 152208Hom.: 84 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
4163
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0300 AC: 7534AN: 250822 AF XY: 0.0305 show subpopulations
GnomAD2 exomes
AF:
AC:
7534
AN:
250822
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0349 AC: 51015AN: 1460118Hom.: 1010 Cov.: 31 AF XY: 0.0346 AC XY: 25161AN XY: 726420 show subpopulations
GnomAD4 exome
AF:
AC:
51015
AN:
1460118
Hom.:
Cov.:
31
AF XY:
AC XY:
25161
AN XY:
726420
show subpopulations
African (AFR)
AF:
AC:
163
AN:
33474
American (AMR)
AF:
AC:
871
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
986
AN:
26106
East Asian (EAS)
AF:
AC:
22
AN:
39692
South Asian (SAS)
AF:
AC:
1446
AN:
86240
European-Finnish (FIN)
AF:
AC:
2517
AN:
52766
Middle Eastern (MID)
AF:
AC:
175
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
42885
AN:
1111018
Other (OTH)
AF:
AC:
1950
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
2349
4699
7048
9398
11747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1566
3132
4698
6264
7830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0273 AC: 4161AN: 152326Hom.: 84 Cov.: 33 AF XY: 0.0275 AC XY: 2045AN XY: 74480 show subpopulations
GnomAD4 genome
AF:
AC:
4161
AN:
152326
Hom.:
Cov.:
33
AF XY:
AC XY:
2045
AN XY:
74480
show subpopulations
African (AFR)
AF:
AC:
255
AN:
41564
American (AMR)
AF:
AC:
344
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
155
AN:
3472
East Asian (EAS)
AF:
AC:
7
AN:
5192
South Asian (SAS)
AF:
AC:
79
AN:
4824
European-Finnish (FIN)
AF:
AC:
559
AN:
10618
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2675
AN:
68030
Other (OTH)
AF:
AC:
71
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
214
428
643
857
1071
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Ehlers-Danlos syndrome, classic type Benign:1
Jul 31, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
Splicevardb
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.